ONCOLife Articles
EU Commission Approves Perioperative Opdivo Regimen for High-Risk Resectable NSCLC
FDA & EMA | 16 May 2025
START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors
Clinical Trials | 15 May 2025
FDA Approves Emrelis as the First Targeted ADC for High c-Met Expressing Lung Cancer
FDA & EMA | 15 May 2025
V Foundation and Cancer Vaccine Coalition Partner to Accelerate Breast Cancer Vaccine
ONCOLife | 14 May 2025
10-Year Results Confirm Pertuzumab Combo Extends Survival in HER2+ Breast Cancer
Clinical Trials | 14 May 2025
Adcentrx’s Nectin-4 ADC, ADRX-0706, Earns FDA Fast Track for Advanced Cervical Cancer
FDA & EMA | 7 May 2025
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Clinical Trials | 13 May 2025
Elraglusib Shows Survival Benefit in First-Line Metastatic Pancreatic Cancer Trial
Clinical Trials
7 May 2025
First-Ever KRAS G12D Inhibitor Zoldonrasib Shows 61% Response Rate in Lung Cancer
Clinical Trials
30 April 2025
Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'
ONCOLife
10 May 2025
POTOMAC Trial: Durvalumab Plus BCG Boosts Outcomes in Early-Stage Bladder Cancer
Clinical Trials
9 May 2025
A Turning Point: Avutometinib + Defactinib Earn Accelerated FDA Approval for Ovarian Cancer
FDA & EMA
9 May 2025
Enhertu Plus THP Outperforms Standard Chemotherapy in Early-Stage HER2+ Breast Cancer
Clinical Trials
7 May 2025
New AI-Powered Urine Test Detects Prostate Cancer with Higher Precision than PSA
ONCOLife
2 May 2025
Pembrolizumab Improves Event-Free Survival in Resectable Head and Neck Cancer
Clinical Trials
28 April 2025
Bayer Launches First-in-Human Trial of Targeted Alpha Therapy for Advanced Liver Cancer
Clinical Trials
30 April 2025
Sasanlimab Plus BCG Shows Significant Survival Benefit for NMI Bladder Cancer
Clinical Trials
26 April 2025
Enhertu Redefines First-Line Treatment for HER2+ Metastatic Breast Cancer
Clinical Trials
23 April 2025
Trodelvy and Keytruda Combination Marks Breakthrough in mTN-Breast Cancer
Clinical Trials
22 April 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
